Zimmer Biomet (NYSE:ZBH) PT Raised to $190.00

ZBH has been the subject of a number of other research reports. BTIG Research raised their price objective on Zimmer Biomet from $160.00 to $173.00 and gave the company a "buy" rating in a research report on Monday, January 25th. Zacks Investment Research lowered Zimmer Biomet from a "hold" rating to a "sell" rating and set a $167.00 price target for the company. in a research report on Wednesday, February 10th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Zimmer Biomet from $146.00 to $160.00 and gave the stock a "hold" rating in a research note on Monday, February 8th. Oppenheimer lifted their target price on shares of Zimmer Biomet from $185.00 to $195.00 and gave the stock an "outperform" rating in a report on Wednesday, May 5th. Finally, JMP Securities increased their price target on shares of Zimmer Biomet from $180.00 to $195.00 and gave the company an "outperform" rating in a report on Tuesday. Two research analysts have rated the stock with a sell rat